Rhythm Pharmaceuticals Inc (RYTM)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
6,767,442,000
EV to revenue ratio (TTM)
27.31
EV to ebitda
-12.65
Financial Performance
Revenue (TTM)
239,918,000
Gross profit (TTM)
213,529,000
EBITDA
-199,550,000
Profitability
Operating margin (TTM)
-68.10%
Profit margin
-85.60%
Return on assets (TTM)
-31.00%
Return on equity (TTM)
-117.10%
Per Share Metrics
Revenue per share (TTM)
3.56
EPS
-3.12
Diluted EPS (TTM)
-3.12
Book value
1.5
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
526.32
PEG ratio
Price to sales ratio (TTM)
28.21
Price to book ratio (TTM)
65.68
Growth
Quarterly earnings growth (YoY)
46.90%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
5
Buy
10
Hold
2
Sell
0
Strong sell
0
Risk & Volatility
Beta
1.968